Graph 1 (Image 01)
Sodium Iodide I 123 Capsule, Gelatin Coated
Product Images NDC 48815-1002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sodium Iodide I 123 (NDC 48815-1002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 418, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (100 uCi Capsule)
This text appears to be a description of radioactive sodium iodide capsules by CardinalHealth. Each capsule contains 3.7 MBq (100 uCi) of iodine 123 and has a half-life of 13.2 hours. The assay confirms the activity of the capsules. The instructions caution users to calculate the correct dosage from the date and time of calibration and to follow the directions for use. They also advise storing the capsules at room temperature.*
Principal Display Panel (200 uCi Capsule)
This is a document from Cardinal Health located in Denver, CO. The document contains information about radioactive medication - iodine 123. The medication has an expiration of 50 hours from the date of calibration and contains 7.4 MBq (200 uCi) per dosage. The document advises the reader to refer to the package insert for directions of use and warns of the medication being radioactive. It also mentions a calibration date and time to calculate the correct dosage. The medication should be stored at room temperature below 86°F.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
